The Cancer Letter

The leading source for information on the issues that shape oncology since 1973

NCI is “really, really sturdy” and won’t break, former directors Ned Sharpless and Kim Rathmell say at UNC Lineberger symposium

Cancer Policy

Ousted CDC director testifies before Senate HELP Committee

CDC’s ACIP makes changes to childhood vaccine recommendations in first meeting since Monarez’s ouster

AACR survey finds overwhelming public support for federal funding for medical and cancer research

FDA cracks down on direct-to-consumer ads, including the Hims & Hers Superbowl blitz

Bipartisan Stem Cell Therapeutic and Research Reauthorization Act of 2025 introduced in the House

After stormy Senate hearing, Trump offers tepid support for RFK Jr. while Kennedy family members call for his ouster

Clinical Roundup

Libtayo + chemo shows significant improvement in OS for advanced NSCLC, phase III EMPOWER-Lung 3 trial shows

Rezatapopt monotherapy shows confirmed responses of eight solid tumor types in PYNNACLE phase II clinical trial

Oral microbes linked to increased risk of pancreatic cancer

Researchers identify key enzyme that pancreatic cancer cells need to obtain vital metabolic nutrients

Glioblastoma cells “unstick” from their neighbors to become more deadly, Sylvester study finds

Outpatient administration of CAR T-cell therapy shows promising outcomes for lymphoma

In The Clinic
Conversation with The Cancer Letter

Will MCD tests revolutionize cancer screening? NCI begins enrollment in Vanguard “feasibility” trial to start finding out

Trials & Tribulations

The Cancer Letter is an independent weekly news publication and the leading source for information on the issues that shape oncology.

Never miss an issue!

Get alerts for our award-winning coverage in your inbox.

Login

Site license subscribers:
Log in with your IP | Register a sponsored account